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Abstract
Background: Complementary and alternative medicine (CAM) use is popular in former Soviet Central Asian
countries including Mongolia. However, no studies are available on CAM use among patients with cancer in
countries of this region. The aim of this research is to describe the prevalence and patterns of CAM use by
patients with cancer in Mongolia.
Methods: A cross-sectional study was conducted using data from 482 cancer patients attending the National Cancer
Center in Mongolia from September 2015 to February 2016. The survey instrument included 25 questions regarding
CAM used, factors associated with use of CAM, cancer-related characteristics, and participants’ socio-demographic profile.
Results: Among 482 respondents (response rate, 95.6%), 47.9% reported using one or more CAM modalities. Products of
animal origin were the most popular modalities of CAM, followed by herbal products. Half of the users used CAM while
receiving conventional treatment of cancer. Among users, only 29% discussed the CAM use with their doctors. Female
gender, younger age, higher education, shorter disease duration, and prior use of CAM were significantly associated with
CAM use.
Conclusions: CAM appears to be widely accepted by patients with cancer in Mongolia. The findings support the urgent
need for further in-depth study into commonly used oral CAM products and their potential effects on health of patients
with cancer in Mongolia. High prevalence of CAM use among cancer patients in our study warrants further studies in
other countries of Central Asia.
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Background
The term complementary and alternative medicine
(CAM) refers to a wide range of products and practices
that are used outside of or alongside with conventional
medicine. Globally, the use of CAM is particularly high
and increasing among patients with cancer [1–9]. The
most pressing concerns associated with such treatments
are safety issues especially when they are used along
with conventional medicine [10, 11]. In addition, the
lack of regulatory oversight raises serious concerns [12].
In the countries of former Soviet Union including
Mongolia, the prevalence of CAM use among general
population ranges from 3.5 to 38% and many people use
CAM for managing symptoms of chronic diseases [13, 14].
Moreover, immigrants from this region who live as ethnic
minorities in the Middle East, East Asia and other countries
have a high preference for using CAM approaches in
several medical conditions [15, 16]. The countries of this
region have also one of the highest incidence rates of can-
cer in the world; however, no studies have focused on the
CAM use among patients with cancer [17]. Hence, there is
a need to conduct a focused study to provide information
that might be useful in the practice, not only to local health
professionals but also to the clinicians in those countries
where Central Asians particularly Mongolians live as ethnic
minorities.
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The purpose of this study was to determine the preva-
lence and patterns of CAM use, especially the specific
CAM products used by cancer patients in Mongolia.
The study also explored perceptions towards CAM use
and predictors for using CAM and its use along with
conventional treatment.
Methods
Setting and participants
Following the descriptive cross-sectional design, the
study was conducted at oncology outpatient clinics
(radiotherapy and/or chemotherapy) at National Cancer
Center (NCC), the only specialized cancer center in
Ulaanbaatar, Mongolia. The National Cancer Center in
Ulaanbaatar has both inpatient and outpatient chemo-
therapy and radiotherapy units where approximately
1300 patients receive the treatment over a period of
6 months. However, for this study only patients attending
the outpatient clinics of chemotherapy and radiotherapy
were surveyed. Moreover, with the help of hospital staff it
was ensured that no patient was surveyed for more than
one time in case they visited the clinics again for follow-
ups during the study period.
Survey instrument
After a literature review, the survey instrument appropri-
ate to local context was initially drafted in English and
assessed by two experienced oncologists, a pharmacist
and a researcher. The questionnaire was then modified ac-
cording to the assessment, translated into the Mongolian
language by a professional translator, and then it was
pilot-tested. Translation accuracy of the survey question-
naire was validated by back-translation into English. After
this, another pilot test was conducted with 20 cancer
patients at different stages of treatment in order to refine
the questionnaire and improve its clarity. The final ques-
tionnaire comprised four sections. The first section had
five questions concerning the individual’s health status,
diagnosis, and whether they were currently receiving con-
ventional cancer treatment. The second section consisted
of 11 questions related to use of CAM. Questions on
patterns of CAM, reasons for use, satisfaction with using
CAM and source of information on CAM were only asked
from respondents who reported using at least one modal-
ity of CAM. The third section contained four questions
asking respondent’s attitudes and beliefs toward CAM.
The last section dealt with five questions showing the
participant’s age, gender, level of income, level of educa-
tion and area of residence. Conventional cancer treatment,
particularly chemotherapy and radiation, are known to
cause a number of side effects [18]. After some literature
review, a list of five common symptoms, which are rou-
tinely experienced by patients with cancer, was included
in the survey instrument. All the respondents (CAM users
and non-users) were asked to report the symptoms for
which they would like to use CAM without a doctor’s
prescription.
Study subjects
The cancer patients attending the oncology outpatient
clinic of the hospital from September 1, 2015 to February
28, 2016 were recruited into this study. The inclusion
criteria were adult patients (over 20 years old) of either
gender with a diagnosis of cancer, aware of their diagnosis
of cancer, able to understand the questions, and willing to
participate in the study. The ethical approval for this sur-
vey was obtained from the School of Medicine at Hanyang
University, South Korea (HYI-15-111-2) and the Ministry
of Health and Sports, Mongolia (No-05). Enrollment was
voluntary and all patients gave written consent to partici-
pate in the study.
Data collection
All patients who met the inclusion criteria during the
study period were invited to participate. Information
about the research was given verbally to each respondent
and consent was sought before the participation. Partici-
pants were informed that they could quit the survey any-
time they wanted to. For interviewing cancer patients,
three experienced interviewers were trained, who
explained the CAM to the study participants administered
the questionnaire. The patients were given the option ei-
ther to fill out the questionnaire themselves or to verbally
respond to the questions asked by the interviewers. In
total, 504 patients agreed to participate in the survey. Of
these, 22 were excluded due to an incomplete question-
naire; so the data of 482 participants were entered into the
database for further analysis. A high response rate of
95.6% shows the willingness of survey respondents to be
helpful as they were ensured complete anonymity.
Statistical analysis
Respondents were categorized as CAM users or
nonusers according to whether they used at least one
modality of CAM for cancer-related outcomes since
diagnosis. The collected data included socio-
demographic and clinical characteristics (type of can-
cer, present medical treatment, and duration since
diagnosis) and CAM use. Comparisons between
categorical variables were executed using Pearson’s
Chi-square test or Fisher’s exact test. Multivariate
logistic regressions were employed for independent
variables to evaluate significant factors that could pre-
dict use of CAM. P-values of < 0.05 were considered
statistically significant. All statistical analyses were
done using Statistical Package for Social Sciences
(SPSS) version 21.0 for Windows.
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Results
Socio-demographic and clinical characteristics
Sociodemographic and clinical characteristics of the sur-
vey participants are presented in Table 1. Out of 482 re-
spondents, the majority were females (63.9%), below
55 years of age (59.5%), from a rural area (66.4%), had less
than or equal to high school education (64.1%) and had
relatively low monthly household income (≤ $300US/
month) (57.1%). The most frequent types of cancer
included gastrointestinal (36.1%), urogenital (29%) and
breast cancers (15.6%). The majority of patients (n = 324;
67.2%) were receiving chemotherapy at the time of study.
Use of CAM and difference between users and non-users
Use of CAM to manage symptoms associated with can-
cer and its treatment was reported by 47.9% (n = 231) of
respondents. Half of users used CAM while receiving
conventional cancer treatment. Survey participants more
Table 1 Respondent characteristics of CAM users and non-CAM users
Variables Total n (%) 482 (100.0) Non-CAM user n (%) 251 (52.1) CAM user n (%) 231 (47.9) P-value
Gender 0.001
Male 174 (36.1) 108 (43) 66 (28.6)
Female 308 (63.9) 143 (57) 165 (71.4)
Age 0.007
< 55 years 287 (59.5) 135 (53.8) 152 (65.8)
> 55 years 195 (40.5) 116 (46.2) 79 (34.2)
Mean age (SD) 51.8 {12.5} 53.1 {12.5} 50.2 {12.4} <0.012*
Residing area 0.792
Urban 162 (33.6) 83 (33.1) 79 (34.2)
Rural 320 (66.4) 168 (66.9) 152 (65.8)
Education level 0.012
No education 4 (0.8) 3 (1.2) 1 (0.4)
Primary education 29 (6) 19 (7.6) 10 (4.3)
Middle/high school 281 (58.3) 157 (62.5) 124 (53.7)
College/university 168 (34.9) 72 (28.7) 96 (41.6)
Household income 0.105
< 300 275 (57.1) 152 (60.6) 123 (53.2)
> 300 207 (42.9) 99 (39.4) 108 (46.8)
Self-perceived health status 0.757
Neither good nor poor 281 (58.3) 148 (59) 133 (57.6)
Good 201 (41.7) 103 (41) 98 (42.4)
Type of cancer 0.02
Breast 75 (15.6) 32 (12.) 43 (18.6)
Gastrointestinal 174 (36.1) 105 (41.8) 69 (29.9)
Urogenital 140 (29) 73 (29.1) 67 (29)
Others 93 (19.3) 41 (16.4) 52 (22.5)
Time since diagnosis <0.001
0–6 months 385 (66) 221 (88) 167 (71)
More than 6 months 97 (34) 30 (12) 64 (29)
Conventional treatment 0.0019
Radiotherapy 96 (19.9) 62 (24.7) 34 (14.7)
Chemotherapy 324 (67.2) 161 (64.1) 163 (70.6)
Radiochemotherapy 62 (12.9) 28 (11.2) 34 (14.7)
Prior use of CAM <0.001
Yes 232 (48.1) 91 (36.2) 141 (61)
No 250 (51.9) 160 (63.7) 90 (39)
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likely to use CAM were female, younger, and had mid-
dle/high school education, were more recently diagnosed
of cancer, had gastro-intestinal or urogenital cancer,
were receiving active chemotherapy, and had used CAM
before diagnosis of cancer (Table 1).
Predictors of CAM use
A logistic regression model was used to assess if any
socio-demographic and clinical characteristics were inde-
pendently associated with the decision to use CAM for
cancer-related outcomes (Table 2). The multiple logistic
regression model shows that CAM use was significantly
associated with female gender (OR 1.749, 95% CI 1.15–
2.658, p = 0.009), younger age (OR 1.662, 95% CI 1.109–
2.493, p = 0.014), higher level of education (OR 1.798, CI
1.196–2.702, p = 0.005), shorter time since diagnosis (OR
2.963, 95% CI 1.364–6.436, p < 0.006), and prior use of
CAM (OR 3.027, 95% CI 2.031–4.513, p < 0.001).
CAM modalities
The frequency of leading CAM modalities along with per-
ceived effectiveness reported by CAM users are listed in
Table 3. Products of animal origin (150 of 231 users,
64.9%) were the most popular modalities of CAM used
for cancer-related outcomes followed by herbal medicine
(32.9%), mind-body therapies (29.4%), dietary supplements
(10.8%), and Mongolian traditional medicine (2.2%). Users
of products of animal origin reported taking 18 different
products while herbal medicine users reported using five
different herbs. Of these products, tripe (37.2%), wild ani-
mal products (18.2%), rhubarb (18.2%), milk bath (16.9%),
and dried foam from a camel’s mouth (16.0%) were most
commonly used. Proportion of users who perceived CAM
as helpful for the purposes they used for are also
presented in Table 3.
Source of information
As illustrated in Table 4, most CAM users obtained infor-
mation about CAM modalities from other cancer patients
(24.7%), followed by family members (22.5%), friends
(19.0%) and mass media and the internet (15.2%). Health
professionals including general practitioners and oncolo-
gists were least likely to recommend use of CAM (6.4%).
Reasons for using CAM
Increasing chance of cure (41.6%) was the most fre-
quently reported reason for using CAM. Patients also
associated the consumption of CAM with boosting the
immune system (35.5%). Other reasons for using CAM
by patients with cancer referred to symptom relief
(18.2%) and others (11.3%) (Table 4).
CAM users’ attitudes and beliefs
Overall, about 65.8% of the CAM users agreed that use of
CAM is generally safe, whilst 23.4% were “neutral” and
10.8% disagreed. Moreover, only 38.1% agreed that con-
current use of CAM and conventional treatment of cancer
is safe, whereas 37.2% disagreed. Of the 231 users, only
29.0% discussed the concurrent use of CAM with their
doctors. Most common reasons for nondisclosure were
doctors did not ask (75.6%) and it was not necessary for
doctors to know (18.9%) (Table 4).
CAM use for managing of symptoms
As shown in Table 5, the majority of patients indicated
that they would consider CAM use for pain manage-
ment (38.2%), fatigue (27.0%), constipation (26.3%) and
nausea and vomiting (21.6%). Anxiety or depression
(17.4%) was least likely to cause use of CAM by patients
with cancer.
Discussion
To our knowledge, the current findings are the first to
report the prevalence and patterns of CAM use among
Mongolian patients with cancer. It also described the
patients’ attitude and beliefs towards concurrent use of
CAM and conventional treatment in oncology setting.
It is believed that Traditional Mongolian Medicine has
derived many techniques and theories from the Trad-
itional Tibetan Medicine. It also integrates some aspects
of Indian Ayurveda and Traditional Chinese Medicine.
In current study, a wide range modalities were included
in CAM, and the results show that the prevalence of
CAM use (47.9%) is similar to a previous study in Japan
[4], but higher than that reported in Europe [6],
Australia [8], and South Korea [19]. This difference of
CAM utilization rate between several studies could be
most likely due to multiple factors such as culture, so-
cioeconomic condition, and/or study methodology itself.
Characteristics of CAM users found in this study were
Table 2 Logistic regression model: association of CAM use with
various factors
Variable Category OR 95% CI P value
Gender Male 1.749 1.15 2.658 0.009
Female
Age ≤55 years 1.662 1.109 2.493 0.014
>55 years
Education level ≤ high school 1.798 1.196 2.702 0.005
Post high school
Time since diagnosis ≤6 months 2.963 1.364 6.436 0.006
>6 months
Prior use of CAM Yes 3.027 2.031 4.513 <0.001
No
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in line with previous studies where female gender, youn-
ger age, higher level of education, prior use of CAM and
shorter time since diagnosis were associated with CAM
use [20, 21].
In evaluating types of CAM modalities used by cancer
patients, we found that products of animal origin were by
far most commonly used. This finding differs from past
studies in which vitamins, minerals and herbs were found
to be more popular than other types of therapy [6, 7].
Some products of animal origin particularly, raw, fermen-
ted or processed dairy products are used as a part of
everyday nutrition by many Mongolians. However, based
on authors’ understanding of the local culture, some
modalities of animal origin were included in CAM
because these products are also consumed as medicine.
Moreover, in a textbook of Mongolian traditional medi-
cine, Norovsambuu has described clinical indications of
several products of animal origin and herbs for a number
of diseases including cancer [22]. Additionally, clinical
indications of some leading products of animal origin such
as tripe have been traced in ancient Chinese dietary medi-
cine texts [23, 24]. According to these texts, tripe has
many properties like strengthening the middle burner
(spleen and stomach) and restoring qi (life force); thus it is
useful for weak people or those who has deficiency of xue
(blood) and qi (life force) [25, 26]. However, most of these
modalities have gained popularity as CAM based on folk
belief and have not yet been evaluated in clinical settings.
Consequently, clinicians and in particular oncologists,
might encounter unwanted effects and complications
among their patients who use such modalities of CAM
[10, 11].
We found that nearly half of the CAM users reported
“increasing chance of cure”, either directly or indirectly,
as the main reason for using CAM. These results are
consistent with previous studies [4, 9]; however, other
studies that have indicated benefits other than cure
(such as, to feel better, to reduce stress and to improve
the quality of life) as the main reason for using CAM
[27, 28]. The majority of users believed that CAM was
effective. However, it is difficult to say whether these
improvements were related to use of CAM, since all
patients received conventional cancer treatment at the
same time. Other patients, family members and friends
were a commonly reported source of information about
CAM. This finding is in agreement with previous studies
investigating the source of information of CAM among
cancer patients [6, 29, 30]. Although the questionnaire
used in the current study did not ask the patients why
they used their social and lay network as a source of
information, Verhoef et al. [31] suggested that it may be
related to patients’ feeling of connection with these
people and thus they consider them as “trusted” source
of health information.
Only about 15% of patients in our sample indicated that
they would consider CAM use for anxiety and/or depres-
sion. This is inconsistent with what is found in previous
studies in the US and South Korea, where patients were
Table 3 Leading CAM modalities reported by cancer patientsa
CAM modality Name of products N – 231 (%) N (%) of users who believed the product helped
Products of animal origin (64.9%) Tripe (goat, sheep etc.) 86 (37.2) 58 (67.4)
Wild animal products 42 (18.2) 29 (69.0)
Milk bath 39 (16.9) 31 (79.5)
Dried foam from camel’s mouth 37 (16.0) 21 (56.8)
Mare’s milk 1 (0.4) 1 (100.0)
Herbal medicine (32.9%) Rhubarb 42 (18.2) 18 (42.9)
Celandine 10 (4.3) 8 (80.0)
Gardenia 8 (3.5) 4 (50.0)
Unknown complex herbal capsules or dragees 7 (3.0) 4 (57.1)
Mushrooms 9 (3.9) 6 (66.7)
Ginseng 3 (1.3) 2 (66.7)
Mind-body therapies (29.4%) Mantra 46 (19.9) 36 (78.3)
Meditation/Yoga 10 (4.3) 8 (80.0)
Massage 5 (2.2) 4 (80.0)
Bone setting 3 (1.3) 3 (100.0)
Others Vitamin/dietary supplements 25 (10.8) 16 (64.0)
Mongolian traditional medicine 5 (2.2) 4 (80.0)
Acupuncture 2 (0.9) 1 (50.0)
amultiple choice question
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using multiple CAM modalities to manage depression and
anxiety [32–34]. Such an inconsistency could be related to
the variety of CAM modalities used by patients with can-
cer. For instance, there is evidence that patients used yoga
therapy to manage anxiety, depression and other
emotional symptoms [34–36]. However, yoga therapy was
not quite popular among sample of this study.
We also found that most of the CAM users believed
CAM to be safe, however, there were split responses
when asked about the concurrent use of CAM and con-
ventional treatment. However, all of the CAM users
were receiving conventional treatment for cancer. Such
results could be due to the social desirability bias, as
during the survey the patients were attending a cancer
hospital for conventional treatment and few of them
might have been afraid to give response in support of
CAM. Similar to past studies, a relatively small propor-
tion of CAM users made their doctors aware of their
decision to use CAM [3, 5]. This could be dangerous,
specifically in the area of oncology, where treatment
methods and procedures are becoming more and more
advanced. The risk of interaction between patients’ use
of CAM by their own decision and conventional treat-
ment might jeopardize their life, as evidence suggests
that consumption of CAM can have negative effects
when used concurrently with conventional radiotherapy
and/or chemotherapy [10, 11]. Therefore, we recom-
mend clinicians to be more aware of their patients’
health care behavior, and more effective communication
approaches should be adopted to ensure safe use of
CAM especially during conventional cancer treatment.
Limitations
There are a few limitations of our study. First, as some
of the questions investigated past events, so recall bias
might have influenced the results. Second, this study
might have overestimated the use of CAM among can-
cer patients as a result of the voluntary response bias.
Patients who had an interest in CAM or were using
CAM modalities may have been more likely to partici-
pate in this study. Moreover, there was a low response
from men with cancer and thus the views expressed by
the study participants may not fully reflect those of the
whole cancer population. As these are the first findings to
report use of CAM in Mongolia, a broad range of CAM
modalities were included in the survey. The authors are
working on another research where Traditional Mongolian
Methods of CAM such as bone art and balneotherapy will
be reported in near future. Despite these limitations, this
study sheds light on different but important aspects of
CAM use among Mongolian patients with cancer.
Conclusions
CAM appears to be widely accepted by patients with
cancer in Mongolia. Health care providers should take the
initiative to ask whether patients are using any CAM, so
they can provide evidence-based consultation regarding
the appropriateness of using CAM during conventional
cancer treatment. Clinicians in those ethnically and
culturally diverse countries where Mongolians are ethnic
minorities should be aware of the fact that many
Table 4 CAM users’ attitudes and beliefs
Category N – 231 %
Source of CAM information
Other patients 57 24.7
Family members 52 22.5
Friends 44 19.0
Mass media/internet 35 15.2
Health professionals 14 6.1
Others 29 12.6
Reasons for using CAMa
To cure the cancer 96 41.6
To boost the immune system 82 35.5
Relief from symptoms 42 18.2
Others 26 11.3
Use of CAM is safe
Agree 152 65.8
Neutral 54 23.4
Disagree 25 10.8
CAM use and conventional cancer treatment is safe
Agree 88 38.1
Neutral 57 24.7
Disagree 86 37.2
Disclosure of CAM use to doctor
Yes 67 29.0
No 164 71.0
Reason for nondisclosure (N – 164)
Doctor did not ask 124 75.6
Not necessary 31 18.9
Fear that doctor would disapprove 9 5.5
amultiple choice question
Table 5 Consideration of CAM use for symptom managementa
Category Total n = 482 CAM user n = 231 Non-user n = 251
Pain management 184 (38.2) 109 (47.2) 75 (29.9)
Fatigue 130 (27.0) 68 (29.4) 62 (24.7)
Constipation 127 (26.3) 70 (30.3) 57 (22.7)
Nausea/vomiting 104 (21.6) 50 (21.6) 54 (21.5)
Anxiety/depression 84 (17.4) 34 (14.7) 50 (19.9)
N (%)
amultiple choice question
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Mongolian cancer patients use modalities of CAM for
cancer-related outcomes. The findings support the urgent
need for further in-depth study into commonly used
CAM products and their potential effects on health of
cancer population in Mongolia. High prevalence of CAM
use among patients with cancer in our study warrants fur-
ther studies in other countries of this region.
Abbreviation
CAM: Complementary and alternative medicine
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